Industry leading cell expression platforms
Celonic offers two standardized cell line development platforms which can be adapted according to the specific needs of our customers.
Innovative industry-leading cell expression platforms
CHOvolution™ is the optimal platform for the high-titer bioproduction of monoclonal antibodies in a fed-batch process, saving time and costs. In case you are dealing with a defucosylated antibody, complex molecule and/or glycosylated protein, our human GEX® platform is the solution.
- SIMPLIFIED LICENSING MODEL
(e.g. no royalties from sales)
- Product derived from CHO and GEX® platforms are in several CLINICAL TRIALS in EU, USA & Asia
- HIGH SCALE-UP STABILITY
- Cell lines suspension-adapted to serum-free EMA- and FDA-COMPLIANT MEDIA
- COMPLIANCE TO cGMP GUIDELINES
- WELL CHARACTERIZED PARENTAL CELL LINE CULTURED UNDER DOCUMENTED ANIMAL-FREE CONDITIONS
- Powered by Celonic's proprietary SEFEX® technology platform
- High productivity (capable of delivering up to 8 g/L for mABs)
- Rapid cell line development: save up to 4 months
- Real Freedom from royalties and binding terms
For more information please contact: